The DOI matches its Crossref record; 10 of the 10 references it cites were found in a registry or an index.
Does central sensitization help explain idiopathic overactive bladder?
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Only a fraction reaches conscious awareness; most contributes to subconscious reflexes coordinating sphincter function and detrusor quiescence.”
From Pelvic Floor Myofascial Dysfunction and Lower Urinary Tract Symptoms: A Mechanism-Based Narrative Review and Proposed Neuro-Musculoskeletal Model (2026) · cites this paper as [1]
In the citing paper
“First, bladder-derived input may be increased because of urothelial dysfunction, detrusor micromotion, or altered receptor sensitivity [1,4].”
From Pelvic Floor Myofascial Dysfunction and Lower Urinary Tract Symptoms: A Mechanism-Based Narrative Review and Proposed Neuro-Musculoskeletal Model (2026) · cites this paper as [1]
In the citing paper
“During normal filling, continuous low-level afferent activity (“afferent noise”) from bladder mechanoreceptors is transmitted to the sacral cord via Aδ-fibers [1].”
From Pelvic Floor Myofascial Dysfunction and Lower Urinary Tract Symptoms: A Mechanism-Based Narrative Review and Proposed Neuro-Musculoskeletal Model (2026) · cites this paper as [1]
In the citing paper
“This input is filtered by the central nervous system, with nonessential signals suppressed while threshold events that initiate voiding are monitored [1].”
From Pelvic Floor Myofascial Dysfunction and Lower Urinary Tract Symptoms: A Mechanism-Based Narrative Review and Proposed Neuro-Musculoskeletal Model (2026) · cites this paper as [1]
In the citing paper
“Referred pain also supports the concept of shared spinal processing; nociceptive input from the pelvic floor muscles converges on dorsal horn neurons that also receive bladder afferents from S2 to S4 [1,5,9,10].”
From Pelvic Floor Myofascial Dysfunction and Lower Urinary Tract Symptoms: A Mechanism-Based Narrative Review and Proposed Neuro-Musculoskeletal Model (2026) · cites this paper as [1]
15 more claims about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Central sensitization: implications for the diagnosis and treatment of pain
Woolf, C. J. (2011) · Pain · doi:10.1016/j.pain.2010.09.030 · Cited by 4,771
Central sensitization: a generator of pain hypersensitivity by central neural plasticity
Latremoliere, A., & Woolf, C. J. (2009) · The Journal of Pain · doi:10.1016/j.jpain.2009.06.012 · Cited by 3,913
Neblett, R., Cohen, H., Choi, Y., Hartzell, M. M., Williams, M., Mayer, T. G., & Gatchel, R. J. (2013) · The Journal of Pain · doi:10.1016/j.jpain.2012.11.012 · Cited by 757
The Somatic Symptom Scale–8 (SSS-8): A Brief Measure of Somatic Symptom Burden
Gierk, B., Kohlmann, S., Kroenke, K., Spangenberg, L., Zenger, M., Brähler, E., & Löwe, B. (2014) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2013.12179 · Cited by 740
Duloxetine for treating painful neuropathy, chronic pain or fibromyalgia
Lunn, M. P., Hughes, R. A., & Wiffen, P. J. (2014) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd007115.pub3 · Cited by 565
Ford, A. C., Quigley, E. M. M., Lacy, B. E., Lembo, A. J., Saito, Y. A., Schiller, L. R., Soffer, E. E., Spiegel, B. M. R., & Moayyedi, P. (2014) · American Journal of Gastroenterology · doi:10.1038/ajg.2014.148 · Cited by 405
The relationship between fibromyalgia and interstitial cystitis
Clauw, D. J., Schmidt, M., Radulovic, D., Singer, A., Katz, P., & Bresette, J. (1997) · Journal of Psychiatric Research · doi:10.1016/s0022-3956(96)00051-9 · Cited by 230
Yunus, M. (2015) · Current Rheumatology Reviews · doi:10.2174/157339711102150702112236 · Cited by 226
Central sensitization in humans: assessment and pharmacology
Arendt-Nielsen, L. (2015) · Handbook of Experimental Pharmacology · doi:10.1007/978-3-662-46450-2_5 · Cited by 125
Lai, H. H., Gardner, V., Ness, T. J., & Gereau, R. W. (2014) · Journal of Urology · doi:10.1016/j.juro.2013.11.099 · Cited by 81
Research works printed but not linked: 166
- Milsom, I. et al. Global prevalence and economic burden of urgency urinary incontinence: a systematic review. Eur. Urol. 65, 79–95 (2014). · DOI · Paper page
- Ju, R., Garrett, J. & Wu, J. M. Anticholinergic medication use for female overactive bladder in the ambulatory setting in the United States. Int. Urogynecol. J. 25, 479–484 (2014). · doi:10.1007/s00192-013-2246-0
- Ganz, M. L. et al. Economic costs of overactive bladder in the United States. Urology 75, 526–532.e18 (2010). · doi:10.1016/j.urology.2009.06.096
- Wein, A. J. Overactive bladder: defining the disease. Am. J. Manag. Care 6, S559–S564; discussion S607–S619 (2000).
- Abrams, P. et al. The standardisation of terminology of lower urinary tract function: report from the Standardisation Sub-committee of the International Continence Society. Neurourol. Urodynam. 21, 167–178 (2002). · DOI · Paper page
- Clemens, J. Q. Afferent neurourology: a novel paradigm. Neurourol. Urodynam. 29 (Suppl. 1), S29–S31 (2010). · doi:10.1002/nau.20792
- Homma, Y. Hypersensitive bladder: a solution to confused terminology and ignorance concerning interstitial cystitis. Int. J. Urol. 21 (Suppl. 1), 43–47 (2014). · DOI
- Phillips, K. & Clauw, D. J. Central pain mechanisms in chronic pain states — maybe it is all in their head. Best Pract. Res. Clin. Rheumatol. 25, 141–154 (2011). · DOI · Paper page
- Yunus, M. B. Central sensitivity syndromes: a new paradigm and group nosology for fibromyalgia and overlapping conditions, and the related issue of disease versus illness. Semin. Arthritis Rheum. 37, 339–352 (2008). · DOI · Paper page
- Baron, R., Hans, G. & Dickenson, A. H. Peripheral input and its importance for central sensitization. Ann. Neurol. 74, 630–636 (2013). · DOI · Paper page
- Mifflin, K. A. & Kerr, B. J. The transition from acute to chronic pain: understanding how different biological systems interact. Can. J. Anaesth. 61, 112–122 (2014). · DOI
- Kandasamy, R. & Price, T. J. The pharmacology of nociceptor priming. Handb. Exp. Pharmacol. 227, 15–37 (2015). · DOI
- Kuner, R. Central mechanisms of pathological pain. Nat. Med. 16, 1258–1266 (2010). · DOI · Paper page
- Mizumura, K. & Murase, S. Role of nerve growth factor in pain. Handb. Exp. Pharmacol. 227, 57–77 (2015). · DOI
- Smith, P. A. BDNF: no gain without pain? Neuroscience 283, 107–123 (2014). · DOI
- Beggs, S., Trang, T. & Salter, M. W. P2X4R+ microglia drive neuropathic pain. Nat. Neurosci. 15, 1068–1073 (2012). · DOI · Paper page
- Old, E. A., Clark, A. K. & Malcangio, M. The role of glia in the spinal cord in neuropathic and inflammatory pain. Handb. Exp. Pharmacol. 227, 145–170 (2015). · DOI · Paper page
- Arendt-Nielsen, L. & Yarnitsky, D. Experimental and clinical applications of quantitative sensory testing applied to skin, muscles and viscera. J. Pain 10, 556–572 (2009). · DOI · Paper page
- Thakur, M., Dickenson, A. H. & Baron, R. Osteoarthritis pain: nociceptive or neuropathic? Nat. Rev. Rheumatol. 10, 374–380 (2014). · DOI · Paper page
- Roussel, N. A. et al. Central sensitization and altered central pain processing in chronic low back pain: fact or myth? Clin. J. Pain 29, 625–638 (2013). · DOI · Paper page
- Zhou, Q. & Verne, G. N. New insights into visceral hypersensitivity — clinical implications in IBS. Nat. Rev. Gastroenterol. Hepatol. 8, 349–355 (2011). · DOI · Paper page
- Kaya, S., Hermans, L., Willems, T., Roussel, N. & Meeus, M. Central sensitization in urogynecological chronic pelvic pain: a systematic literature review. Pain Physician 16, 291–308 (2013). · DOI
- Warren, J. W. Bladder pain syndrome/interstitial cystitis as a functional somatic syndrome. J. Psychosom. Res. 77, 510–515 (2014). · DOI
- Homma, Y. Hypersensitive bladder: towards clear taxonomy surrounding interstitial cystitis. Int. J. Urol. 20, 742–743 (2013). · DOI
- Clemens, J. Q. Afferent neurourology: an epidemiological perspective. J. Urol. 184, 432–439 (2010). · doi:10.1016/j.juro.2010.04.012
- Lai, H. H., Vetter, J., Jain, S., Gereau, R. W. 4th & Andriole, G. L. The overlap and distinction of self-reported symptoms between interstitial cystitis/bladder pain syndrome and overactive bladder: a questionnaire based analysis. J. Urol. 192, 1679–1685 (2014). · DOI
- Schur, E. A. et al. Feeling bad in more ways than one: comorbidity patterns of medically unexplained and psychiatric conditions. J. Gen. Intern. Med. 22, 818–821 (2007). · DOI
- Warren, J. W., Langenberg, P. & Clauw, D. J. The number of existing functional somatic syndromes (FSSs) is an important risk factor for new, different FSSs. J. Psychosom. Res. 74, 12–17 (2013). · DOI
- Lackner, J. M. et al. Type, rather than number, of mental and physical comorbidities increases the severity of symptoms in patients with irritable bowel syndrome. Clin. Gastroenterol. Hepatol. 11, 1147–1157 (2013). · DOI
- Le, H. et al. Co-morbidity of migraine with somatic disease in a large population-based study. Cephalalgia 31, 43–64 (2011). · DOI
- Bullones Rodriguez, M. A. et al. Evidence for overlap between urological and nonurological unexplained clinical conditions. J. Urol. 189, S66–74 (2013). · DOI
- Kim, S. E. & Chang, L. Overlap between functional GI disorders and other functional syndromes: what are the underlying mechanisms? Neurogastroenterol. Motil. 24, 895–913 (2012). · DOI
- Gwilym, S. E. et al. Psychophysical and functional imaging evidence supporting the presence of central sensitization in a cohort of osteoarthritis patients. Arthritis Rheum. 61, 1226–1234 (2009). · DOI · Paper page
- Van Houdenhove, B. & Luyten, P. Central sensitivity syndromes: stress system failure may explain the whole picture. Semin. Arthritis Rheum. 39, 218–219 (2009). · DOI
- Cruz-Almeida, Y. & Fillingim, R. B. Can quantitative sensory testing move us closer to mechanism-based pain management? Pain Med. 15, 61–72 (2014). · DOI · Paper page
- Geber, C. et al. Test-retest and interobserver reliability of quantitative sensory testing according to the protocol of the German Research Network on Neuropathic Pain (DFNS): a multi-centre study. Pain 152, 548–556 (2011). · DOI · Paper page
- Li, J., Simone, D. A. & Larson, A. A. Windup leads to characteristics of central sensitization. Pain 79, 75–82 (1999). · DOI · Paper page
- Chung, O. Y., Bruehl, S., Diedrich, L. & Diedrich, A. The impact of blood pressure and baroreflex sensitivity on wind-up. Anesth. Analg. 107, 1018–1025 (2008). · DOI
- Walker, L. S., Sherman, A. L., Bruehl, S., Garber, J. & Smith, C. A. Functional abdominal pain patient subtypes in childhood predict functional gastrointestinal disorders with chronic pain and psychiatric comorbidities in adolescence and adulthood. Pain 153, 1798–1806 (2012). · DOI · Paper page
- Dengler-Crish, C. M., Bruehl, S. & Walker, L. S. Increased wind-up to heat pain in women with a childhood history of functional abdominal pain. Pain 152, 802–808 (2011). · DOI
- Arebi, N. et al. Distinct neurophysiological profiles in irritable bowel syndrome. Am. J. Physiol. Gastrointest. Liver Physiol. 300, G1086–G1093 (2011). · DOI
- Pfau, D. B., Rolke, R., Nickel, R., Treede, R. D. & Daublaender, M. Somatosensory profiles in subgroups of patients with myogenic temporomandibular disorders and fibromyalgia syndrome. Pain 147, 72–83 (2009). · DOI
- Blumenstiel, K. et al. Quantitative sensory testing profiles in chronic back pain are distinct from those in fibromyalgia. Clin. J. Pain 27, 682–690 (2011). · DOI · Paper page
- Smith, B. W. et al. Habituation and sensitization to heat and cold pain in women with fibromyalgia and healthy controls. Pain 140, 420–428 (2008). · DOI
- Larsson, M. B. et al. Brain responses to visceral stimuli reflect visceral sensitivity thresholds in patients with irritable bowel syndrome. Gastroenterology 142, 463–472 (2012). · DOI · Paper page
- Cagnie, B. et al. Central sensitization in fibromyalgia? A systematic review on structural and functional brain MRI. Semin. Arthritis Rheum. 44, 68–75 (2014). · DOI · Paper page
- Mayer, T. G. et al. The development and psychometric validation of the central sensitization inventory. Pain Pract. 12, 276–285 (2012). · DOI · Paper page
- Neblett, R. et al. Ability of the central sensitization inventory to identify central sensitivity syndromes in an outpatient chronic pain sample. Clin. J. Pain 31, 323–332 (2015). · DOI · Paper page
- Kroenke, K., Spitzer, R. L. & Williams, J. B. The PHQ-15: validity of a new measure for evaluating the severity of somatic symptoms. Psychosom. Med. 64, 258–266 (2002). · DOI · Paper page
- Hauser, W., Brahler, E., Wolfe, F. & Henningsen, P. Patient Health Questionnaire 15 as a generic measure of severity in fibromyalgia syndrome: surveys with patients of three different settings. J. Psychosom. Res. 76, 307–311 (2014). · DOI
- Spiller, R. C. et al. The Patient Health Questionnaire 12 Somatic Symptom scale as a predictor of symptom severity and consulting behaviour in patients with irritable bowel syndrome and symptomatic diverticular disease. Aliment. Pharmacol. Ther. 32, 811–820 (2010). · DOI · Paper page
- Koh, J. S. et al. Depression and somatic symptoms may influence on chronic prostatitis/chronic pelvic pain syndrome: a preliminary study. Psychiatry Investig. 11, 495–498 (2014). · DOI
- Kanai, A. & Andersson, K. E. Bladder afferent signaling: recent findings. J. Urol. 183, 1288–1295 (2010). · doi:10.1016/j.juro.2009.12.060
- Birder, L. et al. Neural control of the lower urinary tract: peripheral and spinal mechanisms. Neurourol. Urodynam. 29, 128–139 (2010). · DOI · Paper page
- Kanai, A. in Handbook of experimental pharmacology (eds Andersson, K. E. & Michel, M. C.) 171–206 (Springer, 2011).
- Chapple, C. Chapter 2: pathophysiology of neurogenic detrusor overactivity and the symptom complex of 'overactive bladder'. Neurourol. Urodynam. 33, S6–S13 (2014). · doi:10.1002/nau.22635
- Yoshimura, N. & de Groat, W. C. Increased excitability of afferent neurons innervating rat urinary bladder after chronic bladder inflammation. J. Neurosci. 19, 4644–4653 (1999). · DOI · Paper page
- Habler, H. J., Janig, W. & Koltzenburg, M. Activation of unmyelinated afferent fibres by mechanical stimuli and inflammation of the urinary bladder in the cat. J. Physiol. 425, 545–562 (1990). · DOI · Paper page
- Mazieres, L., Jiang, C. & Lindstrom, S. The C fibre reflex of the cat urinary bladder. J. Physiol. 513, 531–541 (1998). · doi:10.1111/j.1469-7793.1998.531bb.x
- Xiao, Z. et al. Somatic modulation of spinal reflex bladder activity mediated by nociceptive bladder afferent nerve fibers in cats. Am. J. Physiol. Renal Physiol. 307, F673–F679 (2014). · doi:10.1152/ajprenal.00308.2014
- Gillespie, J. I., van Koeveringe, G. A., de Wachter, S. G. & de Vente, J. On the origins of the sensory output from the bladder: the concept of afferent noise. BJU Int. 103, 1324–1333 (2009). · doi:10.1111/j.1464-410x.2009.08377.x
- Keay, S. K., Birder, L. A. & Chai, T. C. Evidence for bladder urothelial pathophysiology in functional bladder disorders. BioMed Res. Int. 2014, 865463 (2014).
- Chacko, S., Cortes, E., Drake, M. J. & Fry, C. H. Does altered myogenic activity contribute to OAB symptoms from detrusor overactivity? ICI-RS 2013. Neurourol. Urodynam. 33, 577–580 (2014). · doi:10.1002/nau.22599
- Ustinova, E. E., Fraser, M. O. & Pezzone, M. A. Cross-talk and sensitization of bladder afferent nerves. Neurourol. Urodynam. 29, 77–81 (2010). · DOI
- Malykhina, A. P. Neural mechanisms of pelvic organ cross-sensitization. Neuroscience 149, 660–672 (2007). · DOI · Paper page
- Giamberardino, M. A. et al. Viscero-visceral hyperalgesia: characterization in different clinical models. Pain 151, 307–322 (2010). · DOI · Paper page
- Brumovsky, P. R. & Gebhart, G. F. Visceral organ cross-sensitization — an integrated perspective. Auton. Neurosci. 153, 106–115 (2010). · DOI
- Malykhina, A. P., Wyndaele, J. J., Andersson, K. E., De Wachter, S. & Dmochowski, R. R. Do the urinary bladder and large bowel interact, in sickness or in health? ICI-RS 2011. Neurourol. Urodynam. 31, 352–358 (2012). · DOI
- Minagawa, T., Wyndaele, M., Aizawa, N., Igawa, Y. & Wyndaele, J. J. Mechanisms of pelvic organ cross-talk: 2. Impact of colorectal distention on afferent nerve activity of the rat bladder. J. Urol. 190, 1123–1130 (2013). · doi:10.1016/j.juro.2013.03.079
- Wyndaele, M. et al. Mechanisms of pelvic organ crosstalk: 1. Peripheral modulation of bladder inhibition by colorectal distention in rats. J. Urol. 190, 765–771 (2013). · doi:10.1016/j.juro.2013.03.045
- Malykhina, A. P. et al. Hyperexcitability of convergent colon and bladder dorsal root ganglion neurons after colonic inflammation: mechanism for pelvic organ cross-talk. Neurogastroenterol. Motil. 18, 936–948 (2006). · DOI
- Rudick, C. N., Chen, M. C., Mongiu, A. K. & Klumpp, D. J. Organ cross talk modulates pelvic pain. Am. J. Physiol. Regul. Integr. Comp. Physiol. 293, R1191–R1198 (2007). · DOI
- Guo, Y. J. et al. Lower urinary tract symptoms in women with irritable bowel syndrome. Int. J. Urol. 17, 175–181 (2010). · DOI
- Monga, A. K., Marrero, J. M., Stanton, S. L., Lemieux, M. C. & Maxwell, J. D. Is there an irritable bladder in the irritable bowel syndrome? Br. J. Obstet. Gynaecol. 104, 1409–1412 (1997). · DOI
- Wyndaele, M., De Winter, B. Y., Pelckmans, P. & Wyndaele, J. J. Lower bowel function in urinary incontinent women, urinary continent women and in controls. Neurourol. Urodynam. 30, 138–143 (2011). · doi:10.1002/nau.20900
- Wyndaele, M. et al. Exploring associations between lower urinary tract symptoms (LUTS) and gastrointestinal (GI) problems in women: a study in women with urological and GI problems versus a control population. BJU Int. 115, 958–967 (2015). · DOI
- Burgers, R. et al. Functional defecation disorders in children with lower urinary tract symptoms. J. Urol. 189, 1886–1891 (2013). · doi:10.1016/j.juro.2012.10.064
- De Wachter, S. & Wyndaele, J. J. Impact of rectal distention on the results of evaluations of lower urinary tract sensation. J. Urol. 169, 1392–1394 (2003). · doi:10.1097/01.ju.0000053393.45026.4d
- Cardozo, L. & Robinson, D. Special considerations in premenopausal and postmenopausal women with symptoms of overactive bladder. Urology 60, 64–71; discussion 71 (2002). · DOI
- Alling Moller, L., Lose, G. & Jorgensen, T. Risk factors for lower urinary tract symptoms in women 40 to 60 years of age. Obstet. Gynecol. 96, 446–451 (2000). · DOI
- Klingele, C. J., Lightner, D. J., Fletcher, J. G., Gebhart, J. B. & Bharucha, A. E. Dysfunctional urinary voiding in women with functional defecatory disorders. Neurogastroenterol. Motil. 22, e1094–e1284 (2010). · DOI
- Carter, D. & Beer-Gabel, M. Lower urinary tract symptoms in chronically constipated women. Int. Urogynecol. J. 23, 1785–1789 (2012). · doi:10.1007/s00192-012-1812-1
- Coyne, K. S. et al. The prevalence of chronic constipation and faecal incontinence among men and women with symptoms of overactive bladder. BJU Int. 107, 254–261 (2011). · doi:10.1111/j.1464-410x.2010.09446.x
- Yamaguchi, O. et al. Defining overactive bladder as hypersensitivity. Neurourol. Urodynam. 26, 904–907 (2007). · DOI
- Daly, D. & Chapple, C. Relationship between overactive bladder (OAB) and irritable bowel syndrome (IBS): concurrent disorders with a common pathophysiology? BJU Int. 111, 530–531 (2013). · doi:10.1111/j.1464-410x.2013.11019.x
- Fitzgerald, M. P. et al. Childhood urinary symptoms predict adult overactive bladder symptoms. J. Urol. 175, 989–993 (2006). · DOI · Paper page
- Rodrigues, P., Hering, F. & Campagnari, J. C. Involuntary detrusor contraction is a frequent finding in patients with recurrent urinary tract infections. Urol. Intern. 93, 67–73 (2014). · doi:10.1159/000356063
- Saito, M. et al. Bladder dysfunction after acute urinary retention in the rats: a novel over active bladder model. Mol. Cell. Biochem. 333, 109–114 (2010). · doi:10.1007/s11010-009-0210-6
- Parsons, B. A. & Drake, M. J. Animal models in overactive bladder research. Handb. Exp. Pharmacol. 2011, 15–43 (2011). · DOI
- Fitzgerald, M. P., Koch, D. & Senka, J. Visceral and cutaneous sensory testing in patients with painful bladder syndrome. Neurourol. Urodynam. 24, 627–632 (2005). · DOI
- Giamberardino, M. A., Tana, C. & Costantini, R. Pain thresholds in women with chronic pelvic pain. Curr. Opin. Obstet. Gynecol. 26, 253–259 (2014). · DOI
- Ness, T. J., Powell-Boone, T., Cannon, R., Lloyd, L. K. & Fillingim, R. B. Psychophysical evidence of hypersensitivity in subjects with interstitial cystitis. J. Urol. 173, 1983–1987 (2005). · DOI
- Ness, T. J., Lloyd, L. K. & Fillingim, R. B. An endogenous pain control system is altered in subjects with interstitial cystitis. J. Urol. 191, 364–370 (2014). · DOI
- Fujihara, A., Ukimura, O., Iwata, T. & Miki, T. Neuroselective measure of the current perception threshold of A-delta and C-fiber afferents in the lower urinary tract. Int. J. Urol. 18, 341–349 (2011). · DOI
- Wenzler, D. L., Burks, F. N., Cooney, M. & Peters, K. M. Proof of concept trial on changes in current perception threshold after sacral neuromodulation. Neuromodulation 18, 228–231 (2015). · doi:10.1111/ner.12213
- Gleason, J. L. et al. Sacral neuromodulation effects on periurethral sensation and urethral sphincter activity. Neurourol. Urodynam. 32, 476–479 (2013). · doi:10.1002/nau.22319
- Vijaya, G. et al. Antimuscarinic effects on current perception threshold: a prospective placebo control study. Neurourol. Urodynam. 31, 75–79 (2012). · doi:10.1002/nau.21194
- Kenton, K., Lowenstein, L. & Brubaker, L. Tolterodine causes measurable restoration of urethral sensation in women with urge urinary incontinence. Neurourol. Urodynam. 29, 555–557 (2010). · doi:10.1002/nau.20804
- Song, Q. X., Chermansky, C. J., Birder, L. A., Li, L. & Damaser, M. S. Brain-derived neurotrophic factor in urinary continence and incontinence. Nat. Rev. Urol. 11, 579–588 (2014). · DOI
- Bhide, A. A., Cartwright, R., Khullar, V. & Digesu, G. A. Biomarkers in overactive bladder. Int. Urogynecol. J. 24, 1065–1072 (2013). · DOI
- Kim, J. C., Park, E. Y., Seo, S. I., Park, Y. H. & Hwang, T. K. Nerve growth factor and prostaglandins in the urine of female patients with overactive bladder. J. Urol. 175, 1773–1776; discussion 1776 (2006). · DOI · Paper page
- Liu, H. T., Chancellor, M. B. & Kuo, H. C. Decrease of urinary nerve growth factor levels after antimuscarinic therapy in patients with overactive bladder. BJU Int. 103, 1668–1672 (2009). · doi:10.1111/j.1464-410x.2009.08380.x
- Liu, H. T., Chancellor, M. B. & Kuo, H. C. Urinary nerve growth factor levels are elevated in patients with detrusor overactivity and decreased in responders to detrusor botulinum toxin-A injection. Eur. Urol. 56, 700–706 (2009). · doi:10.1016/j.eururo.2008.04.037
- Liu, H. T., Lin, H. & Kuo, H. C. Increased serum nerve growth factor levels in patients with overactive bladder syndrome refractory to antimuscarinic therapy. Neurourol. Urodynam. 30, 1525–1529 (2011). · doi:10.1002/nau.21118
- Wang, L. W., Han, X. M., Chen, C. H., Ma, Y. & Hai, B. Urinary brain-derived neurotrophic factor: a potential biomarker for objective diagnosis of overactive bladder. Int. Urol. Nephrol. 46, 341–347 (2014). · DOI
- Antunes-Lopes, T., Pinto, R., Carvalho-Barros, S., Diniz, P. & Martins-Silva, C. Urinary levels of brain derived neurotrophic factor (BDNF) in women with overactive bladder (OAB) syndrome correlate with the severity of symptoms. Eur. Urol. Suppl. 10, 277–278 (2012). · doi:10.1016/s1569-9056(11)60867-1
- Pinto, R. et al. Trigonal injection of botulinum toxin A in patients with refractory bladder pain syndrome/interstitial cystitis. Eur. Urol. 58, 360–365 (2010). · DOI · Paper page
- Griffiths, D., Tadic, S. D., Schaefer, W. & Resnick, N. M. Cerebral control of the bladder in normal and urge-incontinent women. NeuroImage 37, 1–7 (2007). · DOI · Paper page
- Komesu, Y. M., Ketai, L. H., Mayer, A. R., Teshiba, T. M. & Rogers, R. G. Functional MRI of the brain in women with overactive bladder: brain activation during urinary urgency. Female Pelvic Med. Reconstr. Surg. 17, 50–54 (2011). · DOI
- Griffiths, D. J. Use of functional imaging to monitor central control of voiding in humans. Handb. Exp. Pharmacol. 2011, 81–97 (2011). · DOI
- Coyne, K. S. et al. Risk factors and comorbid conditions associated with lower urinary tract symptoms: EpiLUTS. BJU Int. 103 (Suppl. 3), 24–32 (2009). · DOI · Paper page
- Kaplan, S. A. et al. Systematic review of the relationship between bladder and bowel function: implications for patient management. Int. J. Clin. Pract. 67, 205–216 (2013). · DOI
- de Araujo, M. P. et al. Urodynamic study and quality of life in patients with fibromyalgia and lower urinary tract symptoms. Int. Urogynecol. J. Pelvic Floor Dysfunct. 19, 1103–1107 (2008). · DOI
- Chung, J. H. et al. The association between overactive bladder and fibromyalgia syndrome: a community survey. Neurourol. Urodynam. 32, 66–69 (2013). · DOI
- Brand, K., Littlejohn, G., Kristjanson, L., Wisniewski, S. & Hassard, T. The fibromyalgia bladder index. Clin. Rheumatol. 26, 2097–2103 (2007). · DOI
- Wassem, R., McDonald, M. & Racine, J. Fibromyalgia: patient perspectives on symptoms, symptom management, and provider utilization. Clin. Nurse Spec. 16, 24–28; discussion 29–30 (2002). · DOI
- White, K. P., Speechley, M., Harth, M. & Ostbye, T. The London Fibromyalgia Epidemiology Study: comparing the demographic and clinical characteristics in 100 random community cases of fibromyalgia versus controls. J. Rheumatol. 26, 1577–1585 (1999).
- Eliasson, K., Elfving, B., Nordgren, B. & Mattsson, E. Urinary incontinence in women with low back pain. Man. Ther. 13, 206–212 (2008). · DOI
- Matsumoto, S. et al. Relationship between overactive bladder and irritable bowel syndrome: a large-scale internet survey in Japan using the overactive bladder symptom score and Rome III criteria. BJU Int. 111, 647–652 (2013). · DOI
- Smith, M. D., Russell, A. & Hodges, P. W. Do incontinence, breathing difficulties, and gastrointestinal symptoms increase the risk of future back pain? J. Pain 10, 876–886 (2009). · DOI
- Smith, M. D., Russell, A. & Hodges, P. W. Is there a relationship between parity, pregnancy, back pain and incontinence? Int. Urogynecol. J. Pelvic Floor Dysfunct. 19, 205–211 (2008). · DOI
- Tincello, D. G. & Walker, A. C. Interstitial cystitis in the UK: results of a questionnaire survey of members of the Interstitial Cystitis Support Group. Eur. J. Obstet. Gynecol. Reprod. Biol. 118, 91–95 (2005). · DOI
- Clemens, J. Q. et al. Perceptions of 'urgency' in women with interstitial cystitis/bladder pain syndrome or overactive bladder. Neurourol. Urodynam. 30, 402–405 (2011). · doi:10.1002/nau.20974
- Abrams, P., Hanno, P. & Wein, A. Overactive bladder and painful bladder syndrome: there need not be confusion. Neurourol. Urodynam. 24, 149–150 (2005). · doi:10.1002/nau.20082
- Castro-Diaz, D. et al. Urgency and pain in patients with overactive bladder and bladder pain syndrome. What are the differences? Int. J. Clin. Pract. 68, 356–362 (2014). · DOI
- Klumpp, D. J. & Rudick, C. N. Summation model of pelvic pain in interstitial cystitis. Nat. Clin. Pract. Urol. 5, 494–500 (2008). · DOI
- Kilpatrick, L. A. et al. Gating of sensory information differs in patients with interstitial cystitis/painful bladder syndrome. J. Urol. 184, 958–963 (2010). · DOI
- Twiss, C. et al. Increased startle responses in interstitial cystitis: evidence for central hyperresponsiveness to visceral related threat. J. Urol. 181, 2127–2133 (2009). · DOI
- Farmer, M. A. et al. Brain white matter abnormalities in female interstitial cystitis/bladder pain syndrome: A MAPP Network Neuroimaging Study. J. Urol. 194, 118–126 (2015). · DOI
- Clemens, J. Q., Elliott, M. N., Suttorp, M. & Berry, S. H. Temporal ordering of interstitial cystitis/bladder pain syndrome and non-bladder conditions. Urology 80, 1227–1231 (2012). · DOI
- Nickel, J. C. et al. Interstitial cystitis/painful bladder syndrome and associated medical conditions with an emphasis on irritable bowel syndrome, fibromyalgia and chronic fatigue syndrome. J. Urol. 184, 1358–1363 (2010). · DOI · Paper page
- Warren, J. W., Wesselmann, U., Greenberg, P. & Clauw, D. J. Urinary symptoms as a prodrome of bladder pain syndrome/interstitial cystitis. Urology 83, 1035–1040 (2014). · DOI
- Clemens, J. Q., Meenan, R. T., O'Keeffe Rosetti, M. C., Kimes, T. A. & Calhoun, E. A. Case–control study of medical comorbidities in women with interstitial cystitis. J. Urol. 179, 2222–2225 (2008). · DOI
- Warren, J. W. et al. Antecedent nonbladder syndromes in case-control study of interstitial cystitis/painful bladder syndrome. Urology 73, 52–57 (2009). · DOI · Paper page
- Wu, E. Q. et al. Interstitial cystitis: cost, treatment and co-morbidities in an employed population. PharmacoEconomics 24, 55–65 (2006).
- Langenberg, P. W. et al. Pelvic pain and surgeries in women before interstitial cystitis/painful bladder syndrome. Am. J. Obstet. Gynecol. 202, 286.e1–286.e6 (2010). · DOI
- Warren, J. W., van de Merwe, J. P. & Nickel, J. C. Interstitial cystitis/bladder pain syndrome and nonbladder syndromes: facts and hypotheses. Urology 78, 727–732 (2011). · DOI
- Wu, E. Q. et al. A retrospective claims database analysis to assess patterns of interstitial cystitis diagnosis. Curr. Med. Res. Opin. 22, 495–500 (2006). · DOI
- Kato, K., Sullivan, P. F. & Pedersen, N. L. Latent class analysis of functional somatic symptoms in a population-based sample of twins. J. Psychosom. Res. 68, 447–453 (2010). · DOI
- Arendt-Nielsen, L. et al. The effect of N-methyl-D-aspartate antagonist (ketamine) on single and repeated nociceptive stimuli: a placebo-controlled experimental human study. Anesth. Analg. 81, 63–68 (1995).
- Koppert, W. et al. A new model of electrically evoked pain and hyperalgesia in human skin: the effects of intravenous alfentanil, S+-ketamine, and lidocaine. Anesthesiology 95, 395–402 (2001). · DOI · Paper page
- Gottrup, H. et al. Chronic oral gabapentin reduces elements of central sensitization in human experimental hyperalgesia. Anesthesiology 101, 1400–1408 (2004). · DOI
- Iannetti, G. D. et al. Pharmacological modulation of pain-related brain activity during normal and central sensitization states in humans. Proc. Natl Acad. Sci. USA 102, 18195–18200 (2005). · DOI · Paper page
- Tuchman, M., Barrett, J. A., Donevan, S., Hedberg, T. G. & Taylor, C. P. Central sensitization and CaVα2δ ligands in chronic pain syndromes: pathologic processes and pharmacologic effect. J. Pain 11, 1241–1249 (2010). · DOI
- Wang, H. et al. Effect of morphine and pregabalin compared with diphenhydramine hydrochloride and placebo on hyperalgesia and allodynia induced by intradermal capsaicin in healthy male subjects. J. Pain 9, 1088–1095 (2008). · DOI
- Iyengar, S., Webster, A. A., Hemrick-Luecke, S. K., Xu, J. Y. & Simmons, R. M. Efficacy of duloxetine, a potent and balanced serotonin-norepinephrine reuptake inhibitor in persistent pain models in rats. J. Pharmacol. Exp. Ther. 311, 576–584 (2004). · DOI · Paper page
- Harding, L. M., Kristensen, J. D. & Baranowski, A. P. Differential effects of neuropathic analgesics on wind-up-like pain and somatosensory function in healthy volunteers. Clin. J. Pain 21, 127–132 (2005). · DOI
- Kim, Y. T. et al. Gabapentin for overactive bladder and nocturia after anticholinergic failure. Int. Braz. J. Urol. 30, 275–278 (2004). · DOI
- Marencak, J., Cossons, N. H., Darekar, A. & Mills, I. W. Investigation of the clinical efficacy and safety of pregabalin alone or combined with tolterodine in female subjects with idiopathic overactive bladder. Neurourol. Urodynam. 30, 75–82 (2011). · doi:10.1002/nau.20928
- Steers, W. D. et al. Duloxetine compared with placebo for treating women with symptoms of overactive bladder. BJU Int. 100, 337–345 (2007). · doi:10.1111/j.1464-410x.2007.06980.x
- Di Rezze, S. et al. Duloxetine for the treatment of overactive bladder syndrome in multiple sclerosis: a pilot study. Clin. Neuropharmacol. 35, 231–234 (2012). · doi:10.1097/wnf.0b013e3182613dce
- Hanna-Mitchell, A. T., Kashyap, M., Chan, W. V., Andersson, K. E. & Tannenbaum, C. Pathophysiology of idiopathic overactive bladder and the success of treatment: a systematic review from ICI-RS 2013. Neurourol. Urodynam. 33, 611–617 (2014). · DOI
- Nitti, V. W. et al. Can we predict which patient will fail drug treatment for overactive bladder? A think tank discussion. Neurourol. Urodynam. 29, 652–657 (2010). · DOI
- Riedl, A. et al. Somatic comorbidities of irritable bowel syndrome: a systematic analysis. J. Psychosom. Res. 64, 573–582 (2008). · DOI · Paper page
- Gormley, E. A. et al. Diagnosis and treatment of overactive bladder (non-neurogenic) in adults: AUA/SUFU guideline. J. Urol. 188, 2455–2463 (2012). · DOI · Paper page
- Newman, D. K. & Wein, A. J. Office-based behavioral therapy for management of incontinence and other pelvic disorders. Urol. Clin. North Am. 40, 613–635 (2013). · DOI
- Marti, B. G., Valentini, F. A. & Robain, G. Contribution of behavioral and cognitive therapy to managing overactive bladder syndrome in women in the absence of contributive urodynamic diagnosis. Int. Urogynecol. J. 26, 169–173 (2015). · doi:10.1007/s00192-014-2526-3
- Andersson, K. E. in Bladder Dysfunction in the Adult: The Basis for Clinical Management Current Clinical Urology (eds Wein, A. et al.) 121–220 (Springer, 2014). · DOI
- Thin, N. N. et al. Systematic review of the clinical effectiveness of neuromodulation in the treatment of faecal incontinence. Br. J. Surg. 100, 1430–1447 (2013). · DOI · Paper page
- Chodez, M. et al. Results of sacral nerve neuromodulation for double incontinence in adults. Tech. Coloproctol. 18, 1147–1151 (2014). · doi:10.1007/s10151-014-1231-z
- Thomas, G. P., Dudding, T. C., Rahbour, G., Nicholls, R. J. & Vaizey, C. J. Sacral nerve stimulation for constipation. Br. J. Surg. 100, 174–181 (2013). · DOI
- Govaert, B., Melenhorst, J., van Kleef, M., van Gemert, W. G. & Baeten, C. G. Sacral neuromodulation for the treatment of chronic functional anorectal pain: a single center experience. Pain Pract. 10, 49–53 (2010). · doi:10.1111/j.1533-2500.2009.00318.x
- Jadav, A. M. et al. Does sacral nerve stimulation improve global pelvic function in women? Colorectal Dis. 15, 848–857 (2013). · doi:10.1111/codi.12181
- Peters, K. M. Sacral neuromodulation is an effective treatment for interstitial cystitis/bladder pain syndrome: pro. J. Urol. 188, 2043–2044 (2012). · doi:10.1016/j.juro.2012.09.072
- Powell, C. R. & Kreder, K. J. Long-term outcomes of urgency-frequency syndrome due to painful bladder syndrome treated with sacral neuromodulation and analysis of failures. J. Urol. 183, 173–176 (2010). · doi:10.1016/j.juro.2009.08.142
- Tirlapur, S. A., Vlismas, A., Ball, E. & Khan, K. S. Nerve stimulation for chronic pelvic pain and bladder pain syndrome: a systematic review. Acta Obstet. Gynecol. Scand. 92, 881–887 (2013). · DOI
Cited by
Mechanisms Underlying Overactive Bladder and Interstitial Cystitis/Painful Bladder Syndrome
Grundy, L., Caldwell, A., & Brierley, S. M. (2018) · Frontiers in Neuroscience · doi:10.3389/fnins.2018.00931 · Cited by 149
Urinary Microbiome and Psychological Factors in Women with Overactive Bladder
Wu, P., Chen, Y., Zhao, J., Zhang, G., Chen, J., Wang, J., & Zhang, H. (2017) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2017.00488 · Cited by 99
Barber, J. D., & Biancaniello, C. (2026) · Medicina · doi:10.3390/medicina62101952
Metadata
- Authors
- Reynolds, W. S., Dmochowski, R., Wein, A., & Bruehl, S.
- Venue
- Nature Reviews Urology
- Published
- 2016-06-01
- Volume
- 13
- Issue
- 8
- Pages
- 481-491
- ISSN
- 1759-4812
- 1759-4820
- Cited by
- 91
- References
- 10
- Language
- en
- Licence
- www.springer.com/tdm (tdm)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Does central sensitization help explain idiopathic overactive bladder? https://app.cochat.ai/papers/10.1038/nrurol.2016.95
- The paper
- Reynolds, W. S., Dmochowski, R., Wein, A., & Bruehl, S. (2016). Does central sensitization help explain idiopathic overactive bladder? Nature Reviews Urology. https://doi.org/10.1038/nrurol.2016.95
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.